Singapore markets open in 4 hours 26 minutes

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.6716-0.0355 (-5.02%)
At close: 04:00PM EDT
0.6716 0.00 (0.00%)
After hours: 04:02PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.7071
Open0.7165
Bid0.6603 x 300
Ask0.6836 x 300
Day's range0.6613 - 0.7200
52-week range0.5000 - 4.6700
Volume213,786
Avg. volume646,990
Market cap36.714M
Beta (5Y monthly)0.70
PE ratio (TTM)N/A
EPS (TTM)-2.1900
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.23
  • GlobeNewswire

    Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference

    STAMFORD, Conn., April 02, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that Christopher Posner, President and Chief Executive Officer, will present at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9, 2024, at 8:40 a.m. EDT. A webcast of the presentation can be accessed under "Events & Presentations"

  • GlobeNewswire

    Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024

    STAMFORD, Conn., March 07, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a virtual key opinion leader (KOL) event titled “Meet the NP Experts” on Wednesday, March 27, 2024, at 10:00 a.m. EDT. The event will feature a panel of leaders in the field of neuropathic pruritus who will discuss the epidemiology,

  • Simply Wall St.

    Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report

    As you might know, Cara Therapeutics, Inc. ( NASDAQ:CARA ) last week released its latest full-year, and things did not...